600566.SH
济川药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 24.40
+0.04%Margins
Gross margin
80.0%
EBITDA margin
41.8%
EBIT margin
36.1%
Net margin
29.4%
FCF margin
17.3%
11.6%
Return on equity
9.7%
Return on assets
13.5%
Return on invested capital
0.33x
Asset turnover
CNY 1.3B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026